منابع مشابه
Vitreomacular traction syndrome
DOI: 10.1590/S1679-45082015AI2979 NRS, a woman, 71-year-old, who born in São Paulo, Brazil, sought our care service complaining of progressive low visual and metamorphopsia in the right eyes (RE) for 3 months. She had no-history of comorbidities, ophthalmologic surgeries or eye diseases. Upon examination her best-corrected visual acuity was 20/80 in the RE and 20/20 in the left eye. Funduscopy ...
متن کاملVitreomacular Traction Syndrome
The advent of new technologies such as high definition optical coherence tomography (OCT) has not only provided unprecedented imaging capabilities, but also raised the need to define concepts not yet settled and often confusing such as the vitreomacular traction (VMT) syndrome. While technological advances drive us into the future by clarifying the pathophysiology of many diseases and enabling ...
متن کامل[Non-surgical treatment of vitreomacular traction and macular hole].
Macular hole (MA) is a significant cause of visual acuity (VA) loss in patients over 50 years in our environment. The traction by the vitreous, particularly the posterior hyaloids, on the retina surface plays a leading role in the etiopathogeny of MA. The collagen fibers that comprise the posterior vitreous are firmly joined to the macula and connecting to the internal limiting membrane by mean...
متن کاملInitial experience with ocriplasmin in the treatment of vitreomacular traction.
This study aimed to report the clinical and structural outcomes of intravitreal ocriplasmin in the treatment of vitreomacular interface disorders in two tertiary centers in Brazil. A retrospective study was performed by reviewing medical records and spectral domain optical coherence tomography (SD-OCT) findings of seven patients who were treated with a single ocriplasmin injection. A total of 5...
متن کاملOcriplasmin for Treatment of Vitreomacular Traction: An Update
Pharmacologic vitreolysis with ocriplasmin, a 27 kilodalton serine protease, is an effective nonsurgical treatment option for vitreomacular traction (VMT). Data from phase III clinical studies, including the Microplasmin for Intravitreal Injection-Traction Release without Surgical Treatment (MIVI-TRUST) and Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica
سال: 2016
ISSN: 1755-375X
DOI: 10.1111/aos.13075